Related Experiment Video

Updated: May 29, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Glycated hemoglobin A₁c (HbA₁c) and diabetes: a new era?

Niki Katsiki, Nikolaos Papanas, Dimitri P Mikhailidis

    Current Medical Research and Opinion
    |September 16, 2011
    PubMed

    Insights

    The American Diabetes Association

    Area of Science:

    • Endocrinology
    • Clinical Diagnostics
    • Public Health

    Background:

    • The American Diabetes Association (ADA) released updated guidelines in January 2011 for diagnosing and managing diabetes mellitus (DM).
    • The guidelines affirmed glycated hemoglobin A1c (HbA1c) as an independent diagnostic criterion for DM in the USA.
    • This decision followed some debate but solidified HbA1c's role in diabetes diagnosis.

    Discussion:

    • The inclusion of HbA1c as a diagnostic standard has significant implications for clinical practice globally.
    • This standardization facilitates consistent diagnosis and management of diabetes mellitus.
    • The established role of HbA1c in assessing long-term glycemic control supports its use in diagnosis.

    Key Insights:

    • Glycated hemoglobin A1c (HbA1c) is now a well-established independent criterion for diagnosing diabetes mellitus in the USA.
    • The 2011 ADA guidelines reinforce the importance of HbA1c for both diagnosis and management of DM.
    • This diagnostic shift impacts global clinical practice and diabetes care standards.

    Outlook:

    • Further research may explore the long-term impact of standardized HbA1c diagnostic criteria on patient outcomes.
    • Global adoption of HbA1c as a diagnostic standard could improve diabetes mellitus detection rates.
    • Continued evaluation of diagnostic criteria is essential for advancing diabetes care worldwide.

    Related Concept Videos

    Hyperglycemia01:29

    Hyperglycemia

    Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

    Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
    Diabetes: Management and Pharmacotherapy01:15

    Diabetes: Management and Pharmacotherapy

    The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
    Insulin remains the cornerstone of treatment for most patients with type 1 and many...
    Diabetes Mellitus: Introduction01:26

    Diabetes Mellitus: Introduction

    Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...